See patient information for ZORYVE, a steroid-free, once-daily topical used to treat atopic dermatitis, seborrheic dermatitis, and plaque psoriasis. See Safety and Patient Info.

Zoryve foam 0.3% is a once-daily topical, selective PDE4 inhibitor, which is indicated for the treatment of seborrheic dermatitis in individuals 9 years of age and older. The steroid-free …

Learn more about ZORYVE (roflumilast) foam, a topical treatment for seborrheic dermatitis from Arcutis Biotherapeutics.

ZORYVE is an easy, once-daily, steroid-free topical foam designed to simplify seborrheic dermatitis control. See Safety and Product Info.

Oct 8, 2025 · Zoryve foam is a once-daily, steroid-free topical treatment that can be used anywhere on the body, including hairy areas. Zoryve foam for seborrheic dermatitis in patients …

Roflumilast (ZORYVE) Foam in Seborrheic Dermatitis National Drug Monograph September 2024 VA Pharmacy Benefits Management Services and National Formulary Committee The …

Jul 23, 2025 · Zoryve is a topical cream and foam prescribed to treat plaque psoriasis, atopic dermatitis, and seborrheic dermatitis. Learn about side effects, uses, how to apply, and more.

Please see Patient Information for ZORYVE. APPROVED USE ZORYVE foam is a prescription medicine used on the skin (topical) to treat seborrheic dermatitis in adults and children 9 years …

ZORYVE foam, 0.3%, is a phosphodiesterase 4 inhibitor indicated for the treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older. (1)

May 13, 2024 · In a recent publication in the Journal of Clinical and Aesthetic Dermatology, Arcutis Biotherapeutics, Inc. announced the validation of roflumilast (Zoryve) topical foam, …